{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:28:43Z","timestamp":1786494523885,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56033-3","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:52:33Z","timestamp":1780325553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conditional survival patterns and individualized prognostic prediction in malignant peritoneal mesothelioma"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaofeng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"12","key":"56033_CR1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/thoraxjnl-2021-217709","volume":"77","author":"JP van Kooten","year":"2022","unstructured":"van Kooten, J. P. et al. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: A population-based study. Thorax 77(12), 1260\u20131267. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217709 (2022).","journal-title":"Thorax"},{"issue":"2","key":"56033_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41379-020-00688-4","volume":"34","author":"DB Chapel","year":"2021","unstructured":"Chapel, D. B. et al. Malignant peritoneal mesothelioma: Prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. Mod. Pathol. 34(2), 380\u2013395. https:\/\/doi.org\/10.1038\/s41379-020-00688-4 (2021).","journal-title":"Mod. Pathol."},{"issue":"24","key":"56033_CR3","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"AL Feldman","year":"2003","unstructured":"Feldman, A. L. et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J. Clin. Oncol. 21(24), 4560\u20137. https:\/\/doi.org\/10.1200\/JCO.2003.04.150 (2003).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"56033_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","volume":"19","author":"SJ Henley","year":"2013","unstructured":"Henley, S. J. et al. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003\u20132008. Int. J. Occup. Environ. Health 19(1), 1\u201310. https:\/\/doi.org\/10.1179\/2049396712Y.0000000016 (2013).","journal-title":"Int. J. Occup. Environ. Health"},{"issue":"5","key":"56033_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","volume":"8","author":"A Garcia-Fadrique","year":"2017","unstructured":"Garcia-Fadrique, A. et al. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: A review. J. Gastrointest. Oncol. 8(5), 915\u2013924. https:\/\/doi.org\/10.21037\/jgo.2017.08.01 (2017).","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"56033_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1245\/s10434-019-07425-5","volume":"27","author":"YM Ali","year":"2020","unstructured":"Ali, Y. M. et al. Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on quality of life in patients with peritoneal mesothelioma. Ann. Surg. Oncol. 27(1), 117\u2013123. https:\/\/doi.org\/10.1245\/s10434-019-07425-5 (2020).","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"56033_CR7","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1245\/s10434-023-13528-x","volume":"30","author":"L Calthorpe","year":"2023","unstructured":"Calthorpe, L. et al. National practice patterns in malignant peritoneal mesothelioma: Updates in management and survival. Ann. Surg. Oncol. 30(8), 5119\u20135129. https:\/\/doi.org\/10.1245\/s10434-023-13528-x (2023).","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"56033_CR8","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1245\/s10434-019-08139-4","volume":"27","author":"JC Leinwand","year":"2020","unstructured":"Leinwand, J. C., Taub, R. N., Chabot, J. A. & Kluger, M. D. Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat Series. Ann. Surg. Oncol. 27 (7), 2539\u20132547. https:\/\/doi.org\/10.1245\/s10434-019-08139-4 (2020).","journal-title":"Ann. Surg. Oncol."},{"issue":"36","key":"56033_CR9","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan, T. D. et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J. Clin. Oncol. 27(36), 6237\u201342. https:\/\/doi.org\/10.1200\/JCO.2009.23.9640 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"56033_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2014.08.003","volume":"67","author":"G Ploussard","year":"2015","unstructured":"Ploussard, G. et al. Conditional survival after radical nephroureterectomy for upper tract carcinoma. Eur. Urol. 67(4), 803\u201312. https:\/\/doi.org\/10.1016\/j.eururo.2014.08.003 (2015).","journal-title":"Eur. Urol."},{"issue":"2","key":"56033_CR11","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1097\/SLA.0000000000004473","volume":"276","author":"DW Shin","year":"2022","unstructured":"Shin, D. W. et al. Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma. Ann. Surg. 276(2), e86\u2013e92. https:\/\/doi.org\/10.1097\/SLA.0000000000004473 (2022).","journal-title":"Ann. Surg."},{"issue":"2","key":"56033_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5694\/j.1326-5377.2011.tb04171.x","volume":"194","author":"PD Baade","year":"2011","unstructured":"Baade, P. D., Youlden, D. R. & Chambers, S. K. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med. J. Aust. 194(2), 73\u20137. https:\/\/doi.org\/10.5694\/j.1326-5377.2011.tb04171.x (2011).","journal-title":"Med. J. Aust."},{"issue":"2","key":"56033_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SLA.0000000000004794","volume":"277","author":"SA Rahman","year":"2023","unstructured":"Rahman, S. A. et al. The AUGIS Survival Predictor: Prediction of Long-Term and Conditional Survival After Esophagectomy Using Random Survival Forests. Ann. Surg. 277(2), 267\u2013274. https:\/\/doi.org\/10.1097\/SLA.0000000000004794 (2023).","journal-title":"Ann. Surg."},{"issue":"4","key":"56033_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/JTO.0000000000000472","volume":"10","author":"E Kim","year":"2015","unstructured":"Kim, E. & Thomas, C. R. Jr. Conditional survival of malignant thymoma using national population-based surveillance, epidemiology, and end results (SEER) registry (1973\u20132011). J. Thorac. Oncol. 10(4), 701\u20137. https:\/\/doi.org\/10.1097\/JTO.0000000000000472 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"56033_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1432787","volume":"15","author":"Y Fang","year":"2024","unstructured":"Fang, Y. et al. Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohort. Front Endocrinol (Lausanne) 15, 1432787. https:\/\/doi.org\/10.3389\/fendo.2024.1432787 (2024).","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"56033_CR16","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/JTO.0000000000000649","volume":"10","author":"E Kim","year":"2015","unstructured":"Kim, E., Koroukian, S. & Thomas, C. R. Jr. Conditional Survival of Esophageal Cancer: An Analysis from the SEER Registry (1988\u20132011). J. Thorac. Oncol. 10(10), 1490\u20137. https:\/\/doi.org\/10.1097\/JTO.0000000000000649 (2015).","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"56033_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.06.009","volume":"49","author":"X Meng","year":"2023","unstructured":"Meng, X., Chang, X., Qin, P., Li, Y. & Guo, Y. Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer. Eur. J. Surg. Oncol. 49(9), 106957. https:\/\/doi.org\/10.1016\/j.ejso.2023.06.009 (2023).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"56033_CR18","doi-asserted-by":"publisher","first-page":"10181","DOI":"10.1007\/s00432-023-04952-3","volume":"149","author":"J Luo","year":"2023","unstructured":"Luo, J., Hu, X. & Ge, X. Conditional survival nomogram for monitoring real-time survival of young non-metastatic nasopharyngeal cancer survivors. J. Cancer Res. Clin. Oncol. 149 (12), 10181\u201310188. https:\/\/doi.org\/10.1007\/s00432-023-04952-3 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"56033_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.21.01567","volume":"40","author":"AS Tsao","year":"2022","unstructured":"Tsao, A. S., Pass, H. I., Rimner, A. & Mansfield, A. S. New era for malignant pleural mesothelioma: Updates on therapeutic options. J. Clin. Oncol. 40(6), 681\u2013692. https:\/\/doi.org\/10.1200\/JCO.21.01567 (2022).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"56033_CR20","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.21873\/anticanres.15776","volume":"42","author":"R Shamavonian","year":"2022","unstructured":"Shamavonian, R. et al. Cytoreductive surgery and HIPEC for malignant peritoneal mesothelioma: Outcomes and survival from an Australian centre. Anticancer Res. 42(6), 2939\u20132944. https:\/\/doi.org\/10.21873\/anticanres.15776 (2022).","journal-title":"Anticancer Res."},{"issue":"2","key":"56033_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/j.semtcvs.2019.01.010","volume":"31","author":"S Hasegawa","year":"2019","unstructured":"Hasegawa, S. et al. Surgical risk and survival associated with less invasive surgery for malignant pleural mesothelioma. Semin. Thorac. Cardiovasc. Surg. 31(2), 301\u2013309. https:\/\/doi.org\/10.1053\/j.semtcvs.2019.01.010 (2019).","journal-title":"Semin. Thorac. Cardiovasc. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56033-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56033-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:49:19Z","timestamp":1786492159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56033-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56033"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56033-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data of our study was derived from SEER database. The SEER program collects data from population-based cancer registries with anonymous information. The SEER is a publicly available database, thus no ethical approval is required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25026"}}